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Abstract. Perivascular compartments surrounding the penetrating arteries in the brain are part of a physiologic system, which
facilitates fluids exchange and clearance of solutes from the brain. The perivascular compartments become visible on MRI
when enlarged and are commonly referred to as perivascular spaces (ePVS). Previous studies on the association between
ePVS and dementia have been inconsistent due to varying methods of measuring ePVS. As a frame of reference for future MRI
studies on ePVS, we systematically review the literature on ePVS as a marker of vascular brain injury related to dementia
from population-based as well as hospital-based settings. We identified three longitudinal and ten cross-sectional studies
involving 7,581 persons. Potential outcomes were all-cause dementia, Alzheimer’s disease, and vascular dementia. There
was considerable heterogeneity in ePVS assessment: with studies using either visual inspection or segmentation, examining
different brain locations and implementing different grading scales. Moreover, out of the total of 13 studies, all five studies
on vascular dementia reported an association with presence of basal ganglia ePVS after adjustment for age, gender, and white
matter hyperintensities. For seven studies on Alzheimer’s disease and all-cause dementia, the results were ambiguous. This
review did not identify an independent association of ePVS with prevalent or incident dementia. Harmonized methods for
ePVS assessment, tested across different populations, may benefit future MRI studies on ePVS and dementia.
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INTRODUCTION
Dementia is a common age-related brain disease
with an estimated prevalence of 47 million cases
worldwide in 2015 [1]. Vascular pathology is com-
monly implicated in both vascular dementia (VaD)
and Alzheimer’s disease (AD), the two main sub-
types of dementia [2]. This vascular pathology affects
small vessels in the brain such as arteries, arte-
rioles, venules, and capillaries and hence referred
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to as cerebral small vessel disease (CSVD) [3, 4].
CSVD results in ischemic, hemorrhagic, and inflam-
matory damage through diminished blood flow and
disruption of the blood-brain barrier [5, 6]. Magnetic
resonance imaging (MRI) markers of CSVD include
white matter hyperintensities (WMH), lacunes, and
microbleeds (CMB) [3]. The presence of these CSVD
markers have been associated with a higher incidence
of dementia and cognitive decline in the elderly [7, 8].
Accumulating evidence suggest that perivascu-
lar compartments may be another feature of CSVD
[9]. Perivascular compartments surround perforat-
ing cerebral arteries and are involved in the in- and
outflow of fluid and solutes between the arteries
and the brain interstitial fluid. Vascular stiffening,
inflammation, protein deposits, and disruption of the
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blood-brain barrier, partly due to CSVD decreases the
clearance of solutes from the brain interstitial fluid
[9, 10]. As a consequence, perivascular compartment
may enlarge, which increases their visibility on MRI
as spaces with a signal intensity similar to that of
cerebrospinal fluid. Recently, enlarged perivascular
spaces (ePVS) have been associated with a range of
diseases like traumatic brain injury, stroke, and idio-
pathic normal pressure hydrocephalus. Moreover, the
presence of ePVS has been linked with increased
amyloid- (A) deposition in the leptomeningeal
arteries [11]. In animal models, it was demonstrated
that amyloid drains out of the brain along the base-
ment membranes between smooth muscle cells in
the tunica media of cerebral arteries, referred to as
the intramural peri-arterial drainage pathway [10].
The ePVS are reported to develop secondary to
obstruction by cellular waste and impaired interstitial
fluid elimination [11, 12]. Because of the association
between ePVS and A clearance, several studies have
focused on ePVS and dementia, especially AD.
However, previous studies on the determinants
of ePVS and its consequences have been incon-
sistent with some data reporting associations with
dementia whereas others did not. These differences
may be attributed to varying methods of assessing
ePVS, different study designs and study popula-
tions among others. It is important to compile data
from published studies on ePVS and dementia, which
will provide a frame of reference for future studies
on ePVS.
The aim of the present study was to systematically
review the literature on MRI studies on ePVS as a
marker of brain injury and its relationship to demen-
tia from population-based as well as hospital-based
settings.
MATERIALS AND METHODS
Study selection
The Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) guidelines
were employed in this study [13]. We searched
PubMed for peer-reviewed articles published
between 1966 and 1 December 2018. The following
search terms were included: (PERIVASCULAR or
VIRCHOW-ROBIN) and (NEUROIMAGING or
MAGNETIC-RESONANCE-IMAGING or MRI or
MR) and (ALZHEIMER or VASCULAR-DEMEN-
TIA or MIXED-DEMENTIA or DEMENTIA).
The bibliographies of relevant articles were
screened as well. Relevant studies were then selected
by screening of titles and abstracts. Retrospective
and prospective studies were considered eligible if
they assessed ePVS on MRI at baseline with follow-
up for the development of dementia. Cross-sectional
studies were eligible if they assessed ePVS on MRI
for patients with dementia and controls. Moreover,
NOCTH 3 gene hereditary disorder, i.e., cerebral
autosomal dominant arteriopathy with subcorti-
cal infarcts and leukoencephalopathy (CADASIL),
which are likely to affect cognition due to vascular
damage were also included [14]. Other conditions
such as traumatic brain injury, sleep disturbance,
or hydrocephalus which may affect the cerebral
drainage system through non-vascular causes were
excluded.
All included studies should define ePVS as fol-
lows: fluid-filled spaces that follow the typical course
of an artery as it goes through the grey or white matter
[4]. The STRIVE consortium recommend 3 mm as a
size criterion to discriminate perivascular spaces from
lacunes of presumed vascular origin, as lesions less
than 3 mm in diameter are more likely to be perivas-
cular spaces. On MRI, PVS are mostly linear with
signal intensity similar to that of cerebrospinal fluid
on all sequences. Perivascular spaces can be found
in the basal ganglia, white matter, and brainstem [4].
Lacunes are mostly round or ovoid with a hyperin-
tensive rim on MRI.
This review was limited to studies that examined
ePVS in the basal ganglia (BG-PVS) and/or white
matter (WM-PVS), as these brain areas are espe-
cially of interest in CSVD and are most commonly
examined in previous research due to higher abun-
dance of PVS in these brain regions. For the outcome,
the analysis was restricted to results on all-cause
dementia, AD, or VaD. Both clinical diagnoses by
neurologists, as well as use of common diagnos-
tic criteria for dementia such as the Diagnostic and
Statistical Manual of Mental Disorders-Fourth Edi-
tion (DSM-IV), National Institute of Neurological
and Communicative Disorders and Stroke and the
Alzheimer’s Disease and Related Disorders Asso-
ciation (NINCDS-ADRDA) for AD or National
Institute of Neurological Disorders and Stroke and
Association Internationale pour la Recherche´ et l’
Enseignement en Neurosciences (NINDS-AIREN)
for VaD were accepted [3, 15]. Postmortem studies,
narrative reviews, editorials, and studies in languages
other than English were excluded.
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Data extraction
From all studies the following information were
extracted: number of participants, mean age, study
population, characteristics of the MRI protocol (field
strength, sequences used), methodology for identifi-
cation of ePVS, adjustment variables, and outcome
definition. We also recorded the availability of effect
estimates, i.e., hazard ratios and odds ratios.
RESULTS
The search terms resulted in 176 articles and review
of references returned 1 more article. Thirteen arti-
cles met the aforementioned criteria (Fig. 1) [16–28].
Three studies analyzed longitudinal data [16, 17,
19] and ten were cross-sectional studies [18, 20–28].
Table 1 shows an overview of the included studies.
Study populations
The review included 13 populations, with a total of
7,581 unique subjects. The sample size of individual
studies ranged from 8 to 2,592 subjects. Within
the cross-sectional studies, comparisons were done
between subjects with AD (n = 864), VaD (n = 254),
and normal controls. Three studies compared sub-
jects with all-cause dementia to normal controls [18,
20, 27]. The mean age ranged from 50 to 83 years.
The cross-sectional studies examined subjects from
the general population [21, 22, 24–26], subjects diag-
nosed with CADASIL [18], and subjects who visited
hospital for a wide range of neurological disorders
such as memory or stroke clinics [20, 23, 27, 28].
The three longitudinal studies followed 4,528
unique subjects, with a mean age of 73.7 years. The
follow-up time ranged from 2.3 years (median) to
5.2 years (mean). Two studies reported the number
of cases of all-cause dementia [17, 19], whereas one
study specified the subtypes, i.e., AD and VaD [16].
Two studies examined the general population and one
study examined subjects with probable CAA. Exclu-
sion criteria in most of these studies included: history
of traumatic brain injury, presence of Parkinson’s dis-
ease, prior stroke, mixed-dementia, and presence of
other neurologic diseases.
Fig. 1. Flow-chart of article retrieval procedure.
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Table 1
Overview of included studies
Study Year Participants Design No. of MRI Sequences Mean ePVS ePVS
subjects Age (y) locations assessment
Shams et al. [23] 2017 Memory clinic Cross-sectional 1504 1.5,3T T2 63 BG and WM Count
Banerjee et al. [28] 2017 Memory clinic Cross-sectional 226 3T T1, T2, FLAIR 72 BG and WM Count
Cai et al. [24] 2015 General population Cross-sectional 8 7T T2 78 WM only Volume
Ramirez et al. [26] 2015 General population Cross-sectional 297 1.5T T1, T2 72 BG, WM and Volume
Total
Hansen et al. [22] 2015 General population Cross-sectional 151 1.5T T1, FLAIR 75 BG and WM Count
Burnett et al. [27] 2014 Hospital patients Retrospective 79 1.5,3T FLAIR 83 BG only Count
case-control
Yao et al. [18] 2013 CADASIL patients Cross-sectional 344 1.5T T1, T2, FLAIR 51 BG and WM Count
Chen et al. [25] 2011 Memory clinic Cross-sectional 158 3T T1 75 BG, WM and Count
Total
Patankar et al. [21] 2004 General population Cross-sectional 110 1.5T T1, T2 73 BG and WM Count
Heier et al. [20] 1989 Hospital patients Case-control 176 1.5T ‘Echo’ ∗∗ BG and WM Count
Xiong et al. [19] 2017 CAA Retrospective 158 1.5T T2 74 BG and WM Count
Ding et al. [16] 2017 General population Prospective 2592 1.5T T2, FLAIR 75 BG, WM and Count
Total
Zhu et al. [17] 2010 General population Prospective 1778 1.5T T1, T2 73 BG and WM Count
ACD, all-cause dementia; AD, Alzheimer’s disease; VaD, vascular dementia; C, controls; WM, white matter; BG, basal ganglia; CADASIL,
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; CAA, cerebral amyloid angiopathy. ∗∗Not
described.
Measurement of ePVS
Although all studies defined ePVS, which fulfill the
recently developed criteria of STandards for Report-
Ing Vascular changes on nEuroimaging (STRIVE)
[3], multiple strategies were used for actual measure-
ment of ePVS. Most commonly, ten studies counted
all visible ePVS [17–23, 25, 27, 28] and one study
counted only ePVS with a diameter larger than 3 mm
[16]. Two studies measured the volume of ePVS
[24, 26]. For location, eight studies measured ePVS
separately in the WM (primarily the centrum semio-
vale) and BG. One study restricted analysis to ePVS
in BG. Furthermore, different definitions were used
to determine ‘severe’ burden of ePVS which were
either based on categories (derived from counts data),
size, or weightage of PVS. The following defini-
tions were encountered: presence of >20 ePVS [19,
23, 27], presence of >10 ePVS [17, 18, 28], pres-
ence of ePVS > 2 mm [20], presence of ePVS > 3 mm
[16], and weighting in the location of ePVS [21, 22].
Three studies used continuous measures for ePVS
[22, 24, 26].
The most widely used scale was adapted from
Doubal et al. [29]. This scale codes the burden of
ePVS as following: 0 = no ePVS, 1 = 1–10 ePVS,
2 = 11–20 ePVS, 3 = 21–40 ePVS, and 4 = >40 ePVS.
The number of ePVS was taken from the MRI slide
with the most ePVS on standard axial images, and in
case of asymmetry the most affected hemisphere was
taken.
Eight studies used MRIs with field strength of 1.5
Tesla (1.5T) only. Four studies used both 1.5T and 3T
or only 3T, and the remaining study used 7T MRI. For
MRI protocols, nine studies analyzed ePVS on T2
sequence, the remaining four used T1 and/or Fluid
Attenuated Inversion Recovery (FLAIR) sequences.
Table 1 shows an overview of the methodologies of
individual studies.
Prevalence of ePVS in subjects with dementia
Four studies specifically reported the burden of
ePVS in subjects with dementia [21–23, 25]. All stud-
ies reported the presence of at least one visible ePVS
in the WM or BG. In one 3T MRI study, 10.8% of AD
subjects (mean age 74.6 years) had ‘diffuse’ ePVS,
defined as ePVS in the WM, BG, hippocampus, and
brainstem. These AD subjects had a total of 17 ePVS
on average [25]. Another 3T MRI study found 40.9%
of the subjects with AD related pathology to have
severe WM-PVS compared to 14.7% of the subjects
with subcortical vascular cognitive impairment. In
the same study, 0.91% of subjects with AD related
pathology showed severe BG-PVS compared to 9.5%
of the subcortical vascular cognitive impairment [28].
In a study combining both 1.5T and 3T MRI, 21.3%
of the AD subjects had more than 20 WM-ePVS and
5.4% had more than 20 BG-ePVS. For subjects with
VaD, 29.6% had >20 WM-ePVS and 7.4% had >20
BG-ePVS [23]. A 1.5T MRI study reported ePVS
for both AD (mean age, 74.1 years) and VaD (mean
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age, 76.9 years) subjects according to the following
scale: 0 = no ePVS, 1 = 1–10, 2 = 11–20, 3 = 21–30,
4 = 31–40, and 5 = >40. The mean WM-ePVS scores
were 2.61 (SD 0.1) for AD and 2.53 (SD 0.15) for
VaD. The mean BG-ePVS scores were 2.22 (SD 0.09)
for AD and 2.47 (SD 0.87) for VaD [22]. Another
1.5T MRI study on AD (mean age, 61.6 years) and
VaD (mean age, 64.5 years) subjects, reported a mean
WM-ePVS score of 0.74 (SD 0.6) and 1.03 (SD 0.39),
respectively, where a score of 2 (the maximum) indi-
cated more than 5 ePVS on one or both hemispheres
[21]. Two studies utilized automatic segmentation to
measure ePVS volume [24, 26]. The ‘quantified white
matter PVS density’ in volume percentage on 7T MRI
was 8.0 v/v% among 5 subjects with AD (mean age,
78.2 years) [24]. The ‘median white matter volume’
of PVS was 31.7 mm3 and the ‘median basal ganglia
volume’ of PVS was 10.6 mm3 for subjects with AD
(mean age, 72.7 years) [26].
Adjustment for covariates in ePVS studies
Besides one paper [24], all studies performed sta-
tistical analysis on the association between ePVS and
dementia diagnosis within the context of multivariate
models. Variables were included in statistical analy-
sis on the basis of biology of the disease, as well
as by significance testing, i.e., selection of only those
variables with p-values less than 0.05 or 0.1 in prelim-
inary analysis [19, 23]. Commonly included variables
were age, gender, other MRI-markers, cardiovascular
risk factors, education, and cognitive scores. Table 2
gives a full overview of variables included.
ePVS and prevalent dementia
Seven cross-sectional studies examined a link
between ePVS and diagnosis of AD [21–26, 28]. Two
out of six studies reported an association between
BG-PVS and presence of AD [22, 25]. For WM-
PVS, four out of seven studies found an association
with presence of AD [22, 25, 26, 28]. The total vol-
ume of ePVS was not associated with diagnosis of
AD, but for subjects within the top two quartiles, i.e.,
with a ‘severe’ volume of ePVS, AD diagnosis was
more likely [26]. The single prospective study exam-
ining the incidence of AD did not find an association
with presence of large PVS (>3 mm) at baseline [16].
Table 3 summarizes the studies on ePVS and AD.
Four cross-sectional studies examined the associ-
ation between ePVS and diagnosis of VaD [21–23,
28]. All four studies found BG-ePVS to be asso-
ciated with presence of VaD, except for one study
on memory clinic patients, where the association on
high burden of BG-ePVS (>20) and VaD attenuated
in the presence of age, hypertension, probable CAA,
presence of lacunes, presence of moderate to severe
WMH, probable CAA, strictly deep CAA, strictly
lobar CAA, CMB presence, presence of high CS-PVS
grade (>20) and presence of cSS [23]. An association
between increased burden of WM-ePVS and pres-
ence of VaD was reported for two of the four studies
Table 2
Variables included in multivariate models
Study Year (Subsets of) variables included in models for statistical analysis
Cai et al. [24] 2015 –
Ramirez et al. [26] 2015 Age, Sex, Education, MMSE
Hansen et al. [22] 2015 Age, Sex, WMH
Patankar et al. [21] 2004 Age, Sex, WMH, Atrophy
Chen et al. [25] 2011 Age, Sex, WMH, Atrophy, vascular risk factors, MMSE
Shams et al. [23] 2017 Age, HT, WMH, CAA, MBs, CSS
Yao et al. [18] 2013 Age, Sex, Education, ICH, WMH, CMB, Lacunes
Heier et al. [20] 1989 Age, Sex, HT, WMH
Burnett et al. [27] 2014 Age, Sex (matched)
Xiong et al. [19] 2017 Age, MCI, GCA, MTA, SVD score
Banerjee et al. [28] 2017 Age, HT, Diabetes, Cholesterol, Stroke, PiB positivity, APOE genotype, Lacunes,
deep CMB
Ding et al. [16] 2017 Age, Sex, BMI, Education, Depression, Smoking, HT, Cholesterol, WMH,
Lacunes, MB, APOE genotype
Zhu et al. [17] 2010 Age, Sex, Education, Depression, APOE 4, vascular risk factors, WMH,
Lacunes, BPF
MMSE, Mini-Mental State Examination; WMH, white matter hyperintensities; HT, hypertension; CAA, cerebral amyloid
angiopathy; MB, microbleeds; CSS, cortical superficial siderosis; GCA, global cortical atrophy; MCA, medial cortical
atrophy; SVD, small vessel disease; BPF, brain parenchymal fraction; PD, Parkinson’s disease; TBI, traumatic brain injury;
ICH, intracranial hemorrhage.
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Table 3
Cross-sectional analysis of ePVS and AD
Author MRI Exposure Results (OR if reported with 95%CI)
Shams et al. [23] 1.5, 3T >20 BG-PVS AD, OR 3.2 (95%CI:0.4–25.6)
>20 CSO-PVS OR 1.0 (95%CI: 0.6–1.7)
Hansen et al. [22] 1.5T BG-PVS score Higher score in AD, p < 0.001
CSO-PVS score No intergroup difference
Total-PVS score Total PVS score higher in AD compared to NC
Patankar et al. [21] 1.5T BG-PVS score No difference compared to NC
CSO-PVS score No difference compared to NC
Banerjee et al. [28] 3T >10 BG-PVS AD, OR 0.09 (95%CI: 0.04–0.21)
>10 CSO-PVS AD, OR 5.7 (95%CI: 3.0–10.8)
Ramirez et al. [26] 1.5T BG-PVS volume No significant difference
WM-PVS volume PVS volume in AD > C, p < 0.01
Chen et al. [25] 3T BG-PVS count F = 3.52–13.76, p < 0.05 for PVS subscales
WM-PVS count F = 3.52–13.76, p < 0.05 for PVS subscales
Cai et al. [24] 7T WM-PVS volume Higher volume in AD compared NC, p < 0.05
AD, Alzheimer’s disease; VaD, vascular dementia; OR, odds ratio; CADASIL, cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy.
Table 4
Cross-sectional analysis of ePVS and VaD
Author MRI Exposure Results (OR if reported with 95%CI)
Shams et al. [23] 1.5, 3T >20 BG-PVS OR 11.1 (95%CI: 1.1–112.2)
>20 CSO-PVS OR 1.3 (95%CI: 0.6–2.9)
Hansen et al. [22] 1.5T BG-PVS score Higher score in VaD, p < 0.001
CSO-PVS score No intergroup difference
Total-PVS score Total PVS score higher in VaD compared to NC
Patankar et al. [21] 1.5T BG-PVS score Higher score in VaD, p < 0.001
CSO-PVS score Higher score among VaD, p < 0.01
Banerjee et al. [28] 3T >10 BG-PVS VaD OR 10.8 (95%CI: 4.6–25.2)
>10 CSO-PVS VaD OR 0.18 (95%CI: 0.09–0.34)
AD, Alzheimer’s disease; VaD, vascular dementia; OR, odds ratio; CADASIL, cerebral autosomal dominant arteri-
opathy with subcortical infarcts and leukoencephalopathy; ∗Odds Ratios represent results from univariate analysis,
multi-variate analysis was not reported.
[21]. By contrast, another study comparing AD and
VaD subjects reported that a high number of WM-
ePVS was only associated with AD [28]. Only one
prospective study reported an association between the
presence of large BG-PVS (>3 mm) with incidence of
VaD [16]. Table 4 summarizes the studies on ePVS
and VaD.
Three cross-sectional studies examined ePVS in
relation to presence of all-cause dementia [18, 20,
27]. Of these three, one study involving all-cause
dementia from hospital records, reported that the
association attenuated after adjustment for age [20].
Another hospital based case-control study did not
find the diagnosis of dementia to be more frequent
among cases with high burden of BG-ePVS compared
to controls [27]. For subjects with CADASIL, pres-
ence of WM-ePVS was associated with diagnosis of
all-cause dementia in a baseline model, but no signifi-
cant difference was found after adjustment for WMH
volume, lacunes, and CMBs [18]. In the same study
an association between presence of BG-ePVS and
all-cause dementia attenuated after adjustment for the
‘Brain Parenchymal Fraction’.
ePVS and incident dementia
Three longitudinal studies examined all-cause
dementia [16, 17, 19]. An increased incidence of
all-cause dementia for subjects with high burden of
WM-ePVS (>10), was reported in a 1.5T MRI study
using 6135 person-years of follow-up time (24 cases)
[17]. In a retrospective cohort consisting of subjects
with probable CAA without intracranial hemorrhage,
a borderline association between high burden of
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Table 5
ePVS and incidence of dementia
Study Participants Sample Exposure Outcome Result Follow-up
size (presence of)
Zhu et al. [17] General population 1778 >10 WM-ePVS All cause dementia or
controls
HR 8.1 (95%CI:1.4–47.5)
for all cause dementia
3.5 years (median)
>10 BG-ePVS
HR 3.4 (95%CI:0.5–22.1)
for all cause dementia
Ding et al. [16] General population 2592 1 large BG-PVS
(>3 mm)
All cause dementia,
AD, VaD or
controls
Increased HR for VaD
(not reported)
5.2 years (mean)
1 large PVS total
(>3 mm)
HR 3.34
(95%CI:1.41–7.93)
for VaD
Xiong et al. [19] CAA 158 >20 WM-ePVS All cause dementia or
controls
HR 1.28 (95%CI:
0.97–1.70) for all cause
dementia∗
2.3 years (median)
>20 BG-PVS
Difference not significant
(not reported)
AD, Alzheimer’s disease; VaD, vascular dementia; HR, hazard ratio; CAA, cerebral amyloid angiopathy. ∗Hazard ratio represent result from
univariate analysis, multi-variate analysis result not reported.
WM-ePVS (>20 PVS) and incidence of dementia
was observed which attenuated after adjusting for
age, mild cognitive impairment at baseline, WMH
grade (Fazekas score), global cortical atrophy, medial
temporal atrophy, and the cerebral small vessel dis-
ease [19]. Baseline presence of large PVS (>3 mm)
was associated with higher incidence of dementia
(AD and VaD combined) in a model that adjusted
for age, gender, and timing of the MRI-scan [16]
(Table 5).
DISCUSSION
This systematic review showed considerable het-
erogeneity in the assessment of ePVS and its link with
dementia, which did not permit a valid meta-analysis.
Multiple approaches for ePVS measurement (includ-
ing size) and grading were identified within the span
of 13 studies.
In both cross-sectional and longitudinal studies,
multiple aspects of design and methodology might
have influenced the results on the association between
ePVS and dementia. Choices regarding the MRI pro-
tocol, cut-off values for ePVS quantification, brain
region(s) for ePVS assessment, development of mul-
tivariate models and study populations, all potentially
influenced the reported association between ePVS
and dementia.
The results from previous studies offer minimal
support for an association between BG-ePVS and
VaD. All four cross-sectional studies and the single
prospective study found BG-ePVS to be associated
with presence of VaD. For AD, the results are less
clear; four out of seven studies reported an association
between WM-ePVS and presence of AD. An associ-
ation of WM-ePVS and BG-ePVS with AD and VaD
would suggest that the distribution of ePVS partly
reflects the underlying disease process. Although
there appears to be considerable overlap in BG-ePVS
and WM-ePVS pathology [23], earlier studies did
show BG-ePVS to be associated with the presence
of hypertensive vasculopathy and WM-ePVS with
presence of CAA [11, 30–32].
Impaired clearance of cerebral interstitial fluid
and solutes is associated with different concurrent
processes like inflammation, blood-brain barrier dis-
ruption, and impaired vascular pulsatility. The ePVS
may be a biomarker for impaired waste clearance as
well as CSVD, because deposition of A plaques and
hypertensive arteriosclerosis appear to be involved
[9, 33]. Indeed, it has been shown before that perivas-
cular spaces can only be detected around penetrating
arteries in the basal ganglia and white matter. Perivas-
cular spaces are not seen around cortical arteries
as layers of smooth muscle, basement membrane,
and one layer of leptomeninges are all compressed
together [34]. The included populations showed con-
siderable differences in the presence of CSVD risk
factors. For example, the prevalence of hyperten-
sion ranged from 25% to about 80%. Two studies
excluded subjects with prior (silent) stroke [19, 22].
Other studies specifically examined subjects with a
high burden of CSVD [18, 19]. Enlarged perivascular
spaces were associated with poor sleep quality among
patients evaluated for cerebrovascular disease [35].
None of the studies considered for inclusion in this
254 D. Smeijer et al. / Enlarged Perivascular Spaces and Dementia
review excluded subjects due to presence of sleep dis-
orders. One case-control study mentioned the number
of included subjects with sleep disorders. Here, sleep
disorders were not frequent among cases, i.e., those
with an ‘e´tat crible´’ on MRI [27].
With advancing age and high burden of CSVD,
mixed pathology is also found in the brain which
undermines the predictive abilities of individual brain
regions for AD or VaD. Increasing burden of WMH
with advancing age might obliterate ePVS grading
[22]. Several studies which did adjust for variables
like age, WMH, lacunes, and brain atrophy, reported
an attenuation in the link between ePVS and dementia
[17, 19, 20, 23]. Knowledge on potential confounders
should be incorporated to elucidate to which extend
the association between ePVS and dementia is influ-
enced by other factors.
The studies that found an association between
WM-ePVS and AD used stronger field strength:
mostly 3T versus primarily 1.5T. The visibility of
ePVS is influenced by the field strength and proto-
col of the MRI scanner. A comparison of 1.5T and
3T MRI, showed better definition of ePVS in the
higher field strength, i.e., 3T MRI [26]. However,
detection of more physiologic ePVS may result in
over estimation of ePVS. A 7T MRI study on ePVS
found on average 71 PVS (SD 28) in the WM among
the general population. According to the methods
encountered in the included studies, all subjects with
71 WM-ePVS would be placed in the highest cat-
egory of ePVS burden (severe) [36]. The 7T MRI
may have additional value through improved detec-
tion, morphological analysis, and 3D tracing of PVS.
Further, the perforating arteries of PVS can be visual-
ized noninvasively, hence vascular changes in relation
to enlargement of PVS can be studied in vivo [37].
However, few clinical 7T MRI studies on CSVD
have been published and it will take time to develop
new methodological standards. In this regard, (semi)
automated methods become a necessity, as visual
counting on 7T is not feasible due to increased num-
ber of visible perivascular spaces.
The visibility of PVS on MRI might not be suf-
ficient to label them as pathologically enlarged. In a
pathology study, size did appear to be the most impor-
tant factor to discriminate PVS from lacunar infarcts
[38]. Most ePVS are smaller than 3 mm, but the dis-
tinction from lacunes can be difficult and multiple
studies acknowledged the potential misclassification
of lacunes and ePVS. The location for ePVS mea-
surement might have affected the results of studies
as well. A significant association between WM-
ePVS and dementia incidence, could not be replicated
by another study on hippocampal ePVS within the
same population, despite 74% more person-years of
follow-up [17, 39].
The two studies that used automated segmentation
for ePVS found an association between WM-ePVS
and AD. These automated approaches take into
account larger parts of the brain and therefore might
be more representative. Visual counting of PVS is
labor intensive and selection of the most severe slide
might add subjectivity to the measurement. A recent
study reported a good generalizability of single-slice
counting to the total PVS within the whole brain [40].
On the contrary, another study found poor correla-
tions between the single-slice visual rating scale from
Doubal et al. (which selects the most severely affected
slide) and whole-brain volumetrics of the WM-ePVS
(ρ = 0.41) or BG-ePVS (ρ = 0.38) [26]. There is no
international standard on ePVS assessment yet. How-
ever, the visual grading scale developed by Doubal et
al. remains the most widely used in previous studies
due to its easy administration. A recently published
meta-analysis on cognitive impairment and dementia
was able to harmonize ratings across five different
studies [41]. Such initiatives might improve valida-
tion of results across countries. The cross-sectional
studies in this review were unable to answer whether
ePVS preceded other aspects of CSVD. CADASIL
appeared to accelerate development of ePVS among
subjects who are 50 years old as compared to general
population where the higher burden of ePVS are only
seen two decades later [18].
The strength of this review is that it gives a rep-
resentative overview of current literature on ePVS
and dementia, using a reproducible search strategy.
This review identified strong heterogeneity in the
assessment of ePVS. Because of the limited num-
ber of studies and use of multiple study-designs,
the use of a validated questionnaire for quality
assessment was not feasible. To present a comprehen-
sive overview, both prospective and cross-sectional
designs, small and large samples, and different study
populations were accepted for inclusion. It was not
possible to assess publication bias, because studies
on ePVS are not necessarily registered in trial reg-
istries. We encountered considerable heterogeneity in
methodologies and, possibly as a consequence, found
inconsistent results on the association between ePVS
and dementia.
Although guidelines exist on MR imaging of
ePVS, a ‘gold standard’ for valid assessment of ePVS
is lacking. Unfortunately, we were unable to over-
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come these aspects with a valid meta-analysis, due
to insufficient effect measures and different study
designs. Some aspects intrinsic to the studies might
have influenced this review. Two studies of case-
control design that retrospectively checked hospital
records for cases of dementia questions the reli-
ability of their case definition [20, 27]. The use
of more consistent inclusion, and exclusion crite-
ria, could help distinguish the role of CSVD from
other pathogenic factors, like the presence of stroke,
traumatic brain injury, or sleep disorder, that also
contribute to impaired solute clearance and the devel-
opment of dementia.
Conclusion
This review encountered considerable heterogene-
ity in the assessment of ePVS. More longitudinal data
and analysis of ePVS within multivariate models that
incorporate current understanding could help further
elucidate the role of ePVS in dementia. Consistent
and harmonized use of methods, tested across differ-
ent populations, would benefit future MRI studies on
the association between ePVS and dementia.
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